Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Federal Trade Commission
Cantor Fitzgerald
Cipla
Healthtrust
Julphar
Express Scripts
Covington
Johnson and Johnson

Generated: October 21, 2017

DrugPatentWatch Database Preview

Bracco Company Profile

« Back to Dashboard

What is the competitive landscape for BRACCO, and when can generic versions of BRACCO drugs launch?

BRACCO has forty-three approved drugs.

There are three US patents protecting BRACCO drugs.

There are one hundred and fifty-six patent family members on BRACCO drugs in twenty-eight countries and thirty-eight supplementary protection certificates in nine countries.

Summary for Applicant: Bracco

International Patents:156
US Patents:3
Tradenames:65
Ingredients:37
NDAs:43
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
KINEVAC
sincalide
INJECTABLE;INJECTION017697-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► SubscribeY ► Subscribe
Bracco
CARDIOGEN-82
rubidium chloride rb-82
INJECTABLE;INJECTION019414-001Dec 29, 1989RXNoNo► Subscribe► Subscribe► Subscribe
Bracco
CYSTOGRAFIN DILUTE
diatrizoate meglumine
SOLUTION;URETHRAL010040-022Nov 9, 1982RXYesNo► Subscribe► Subscribe► Subscribe
Bracco
RUBRATOPE-60 KIT
cobalt chloride co-60; cyanocobalamin; cyanocobalamin co-60; intrinsic factor
N/A;N/A016090-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
RENOVUE-DIP
iodamide meglumine
INJECTABLE;INJECTION017903-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
LUMASON
sulfur hexafluoride lipid-type a microspheres
FOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-004Nov 23, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Bracco
ISOVUE-128
iopamidol
INJECTABLE;INJECTION018735-005Oct 21, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
ISOVUE-370
iopamidol
INJECTABLE;INJECTION020327-004Oct 12, 1994RXYesYes► Subscribe► Subscribe► Subscribe
Bracco
RENOGRAFIN-60
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION010040-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
PROHANCE MULTIPACK
gadoteridol
INJECTABLE;INJECTION021489-001Oct 9, 2003► Subscribe► Subscribe
Bracco
ISOVUE-300
iopamidol
INJECTABLE;INJECTION020327-003Oct 12, 1994► Subscribe► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-001Nov 23, 2004► Subscribe► Subscribe
Bracco
ISOVUE-M 200
iopamidol
INJECTABLE;INJECTION018735-001Dec 31, 1985► Subscribe► Subscribe
Bracco
ISOVUE-300
iopamidol
INJECTABLE;INJECTION018735-002Dec 31, 1985► Subscribe► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-003Nov 23, 2004► Subscribe► Subscribe
Bracco
CARDIOGEN-82
rubidium chloride rb-82
INJECTABLE;INJECTION019414-001Dec 29, 1989► Subscribe► Subscribe
Bracco
PROHANCE
gadoteridol
INJECTABLE;INJECTION020131-001Nov 16, 1992► Subscribe► Subscribe
Bracco
CHOLETEC
technetium tc-99m mebrofenin kit
INJECTABLE;INJECTION018963-001Jan 21, 1987► Subscribe► Subscribe
Bracco
PROHANCE MULTIPACK
gadoteridol
INJECTABLE;INJECTION021489-001Oct 9, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Bracco

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,592,846 Long-lasting aqueous dispersions or suspensions of pressure resistant gas-filled microvesicles and methods for thereof preparation thereof► Subscribe
5,531,980 Stable microbubbles suspensions injectable into living organisms► Subscribe
6,896,875 Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging► Subscribe
5,908,610 Stable microbubble suspensions comprising saturated phospholipios for ultrasonic echography► Subscribe
5,863,520 Method of echographic imaging using polymeric gas or air filled microballoons► Subscribe
5,840,275 Ultrasonic contrast agent with polymeric gas or air filled microballoons► Subscribe
6,110,443 Dry stable formation to produce microbubble suspension for ultrasound► Subscribe
5,271,928 Stable microbubbles suspensions injectable into living organisms► Subscribe
5,578,292 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof► Subscribe
6,183,725 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Bracco Drugs

Country Document Number Estimated Expiration
JapanH05255127► Subscribe
Japan2003221350► Subscribe
Spain2098015► Subscribe
Spain2192572► Subscribe
Iceland3707► Subscribe
Greece3022461► Subscribe
Finland943167► Subscribe
Austria146972► Subscribe
China1756557► Subscribe
Netherlands300061► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Bracco Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90064-1Sweden► SubscribePRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
C/GB08/036United Kingdom► SubscribePRODUCT NAME: MICAFUNGIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN PARTICULAR MICAFUNGIN SODIUM; REGISTERED: UK EU/1/08/448/001 20080425; UK EU/1/08/448/002 20080425
595Luxembourg► SubscribePRODUCT NAME: SIMEPREVIR, OU L UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, INCLUANT SIMEPREVIR SODIUM. FIRST REGISTRATION: 20140516
C0055France► SubscribePRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
90020-1Sweden► SubscribePRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
00061Netherlands► SubscribePRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
C/GB97/078United Kingdom► SubscribePRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
C/GB98/025United Kingdom► SubscribePRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
2015 00014Denmark► SubscribePRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
/2001Austria► SubscribePRODUCT NAME: SCHWEFELHEXAFLUORID ENTHALTENDE, DURCH PHOSPHORLIPID STABILISIERTE MIKROBLAESCHEN; REGISTRATION NO/DATE: EU/1/01/177/001, EU/1/01/177/002 20010326
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Moodys
Farmers Insurance
Accenture
Medtronic
Cantor Fitzgerald
Citi
AstraZeneca
Daiichi Sankyo
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot